Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP70 is a processed pseudogene belonging to the ribosomal protein L7a (RPL7A) family. Pseudogenes are nonfunctional copies of genes created through reverse transcription and reintegration into the genome; they typically lack regulatory elements or sequences needed to encode functional proteins. RPL7AP70 does not encode a protein, is not a component of the ribosome, and has no therapeutic or biological activity. Such pseudogenes are common and sometimes confused with their protein-coding counterparts, but should not be listed as drug targets[4]. If you are searching for the *functional* ribosomal protein, the correct entity is **60S ribosomal protein L7a** (gene symbol: RPL7A)[1][3]. RPL7A is a bona fide ribosomal protein with biological functions in translation, but RPL7AP70 is not.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 70 (RPL7AP70).